A Quality Improvement Initiative to Standardize <i>Pneumocystis jirovecii</i> Pneumonia Prophylaxis in Pediatric Patients With Solid Tumors
A universal approach to PJP prophylaxis can be safely and effectively implemented in pediatric patients with ST without significant toxicity. Our experience highlights how change management models can effectively support the implementation of QI initiatives in pediatric oncology.
Authors
- Elyse J. Zelunka
- Sarah Cohen‐Gogo (ORCID: https://orcid.org/0000-0002-8852-1104)
- Paul Craig Nathan (ORCID: https://orcid.org/0000-0003-0334-0871)
- Furqan Shaikh (ORCID: https://orcid.org/0000-0001-7069-0359)
- Mark Irwin
- Dana Connolly
- Kriti Kumar
- Karla Kerrigan
- Ellen Kellington
Institutions
- University of Toronto (CA)
- Hospital for Sick Children (CA)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1002/1545-5017.70015
- Primary Topic
- Pneumocystis jirovecii pneumonia detection and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00